Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Sanofi India Limited
SANOFISanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. It also exports its products to approximately 35 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH. Address: Sanofi House, Mumbai, India, 400072
Analytics
WallStreetin tavoitehinta
684 962.24 INRP/E-suhde
26.8099Osinkotuotto
2.72 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut SANOFI
Osinkoanalytiikka SANOFI
Osinkojen kasvu 5 vuoden aikana
430 %Jatkuva kasvu
–Maksusuhde 5 vuoden keskiarvo
132 %Osinkohistoria SANOFI
Osakkeen arvostus SANOFI
Talousasiat SANOFI
Tuloksia | 2019 | Dynamiikka |